PRMT1 and breast neoplasm: Splicing analysis has revealed that PRMT1 expression is associated with alternative splicing disorders in breast tumor samples [71], and mass spectrometry-based proteomics on BC patient-derived xenograft (PDX) tumors has revealed that PRMT1 substrates include proteins involved in RNA processing [72].